iNOS activity is critical for the clearance of Burkholderia mallei from infected RAW 264.7 murine macrophages

Cellular Microbiology

Volumn 10, Issue 2, 2008, Pages 487-498

  Brett, Paul J ^a   Burtnick, Mary N ^a   Su, Hua ^a   Nair, Vinod ^a   Gherardini, Frank C ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; BETA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 6; RANTES; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL SURVIVAL; BURKHOLDERIA; ENZYME ACTIVITY; ENZYME ANALYSIS; HOST RESISTANCE; IMMUNOBLOTTING; MACROPHAGE; MACROPHAGE FUNCTION; MONOLAYER CULTURE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANIMALS; BURKHOLDERIA MALLEI; CELL LINE; ENZYME ACTIVATION; ENZYME INHIBITORS; ESCHERICHIA COLI; GUANIDINES; INTERFERON-BETA; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE SYNTHASE TYPE II;

ANIMALIA; BURKHOLDERIA MALLEI; MURINAE;

EID: 38049155878     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2007.01063.x     Document Type: Article

References (54)

1. Bartlett, J.G. (2005) Glanders. In Infectious Diseases. Gorbach, S.L., Bartlet, J.G., and Blacknow, N.R. (eds). Lippincott Williams & Wilkins, pp. 1463-1464.
2. Barton, G.M., and Medzhitov, R. (2003) Toll-like receptor signaling pathways. Science 300: 1524-1525.
3. Boehm, U., Klamp, T., Groot, M., and Howard, J.C. (1997) Cellular responses to interferon-gamma. Annu Rev Immunol 15: 749-795.
4. Breitbach, K., Klocke, S., Tschernig, T., van Rooijen, N., Baumann, U., and Steinmetz, I. (2006) Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice. Infect Immun 74: 6300-6309.
5. Breitbach, K., Rottner, K., Klocke, S., Rohde, M., Jenzora, A., Wehland, J., and Steinmetz, I. (2003) Actin-based motility of Burkholderia pseudomallei involves the Arp 2/3 complex, but not N-WASP and Ena/VASP proteins. Cell Microbiol 5: 385-393.
6. Brett, P.J., Burtnick, M.N., Snyder, D.S., Shannon, J.G., Azadi, P., and Gherardini, F.C. (2007) Burkholderia mallei expresses a unique lipopolysaccharide mixture that is a potent activator of human Toll-like receptor 4 complexes. Mol Microbiol 63: 379-390.
7. Carpenter, S., and O'Neill, L.A. (2007) How important are Toll-like receptors for antimicrobial responses? Cell Microbiol 9: 1891-1901.
8. Coleman, J.W. (2001) Nitric oxide in immunity and inflammation. Int Immunopharmacol 1: 1397-1406.
9. Collins, H.L., and Kaufmann, S.H.E. (2001) Immune responses to intracellular bacteria. In Clinical Immunology: Principles and Practice. Rich, R.R., Fleisher, T.A., Shearer, W.T., Kotzin, B.L., and Schroeder, H.W., Jr. (eds). Mosby, pp. 26.1-26. 16.
10. Dance, D.A.B. (1996) Melioidosis and glanders. In Oxford Textbook of Medicine. Weatherall, D.J., Ledingham, J.G.G., and Warrell, D.A. (eds). Oxford: Oxford University Press, pp. 590-595.
11. De Soyza, A., Ellis, C.D., Khan, C.M., Corris, P.A., and Demarco de Hormaeche, R. (2004) Burkholderia cenocepacia lipopolysaccharide, lipid A, and proinflammatory activity. Am J Respir Crit Care Med 170: 70-77.
12. DeShazer, D., Waag, D.M., Fritz, D.L., and Woods, D.E. (2001) Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant. Microb Pathog 30: 253-269.
13. Duval, C.W., and White, P.G. (1907) The histological lesion of experimental glanders. J Exp Med 9: 352-384.
14. Fang, F.C. (2004) Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol 2: 820-832.
15. Harley, V.S., Dance, D.A., Drasar, B.S., and Tovey, G. (1998) Effects of Burkholderia pseudomallei and other Burkholderia species on eukaryotic cells in tissue culture. Microbios 96: 71-93.
16. Howe, C., and Miller, W.R. (1947) Human glanders: Report of six cases. Ann Intern Med 26: 93-115.
17. Inglis, T.J., Robertson, T., Woods, D.E., Dutton, N., and Chang, B.J. (2003) Flagellum-mediated adhesion by Burkholderia pseudomallei precedes invasion of Acanthamoeba astronyxis. Infect Immun 71: 2280-2282.
18. Jacobs, A.T., and Ignarro, L.J. (2001) Lipopolysaccharide-induced expression of interferon-beta mediates the timing of inducible nitric-oxide synthase induction in RAW 264.7 macrophages. J Biol Chem 276: 47950-47957.
19. Jones, A.L., DeShazer, D., and Woods, D.E. (1997) Identification and characterization of a two-component regulatory system involved in invasion of eukaryotic cells and heavy-metal resistance in Burkholderia pseudomallei. Infect Immun 65: 4972-4977.
20. Kespichayawattana, W., Rattanachetkul, S., Wanun, T., Utaisincharoen, P., and Sirisinha, S. (2000) Burkholderia pseudomallei induces cell fusion and actin-associated membrane protrusion: A possible mechanism for cell-to-cell spreading. Infect Immun 68: 5377-5384.
21. Knodler, L.A., Vallance, B.A., Hensel, M., Jäckel, D., Finlay, B.B., and Steele-Mortinmer, O. (2003) Salmonella type III effectors PipB and PipB2 are targeted to detergent-resistant microdomains on internal host cell membranes. Mol Microbiol 49: 685-704.
22. Lamothe, J., Huynh, K.K., Grinstein, S., and Valvano, M.A. (2007) Intracellular survival of Burkholderia cenocepacia in macrophages is associated with a delay in the maturation of bacteria-containing vacuoles. Cell Microbiol 9: 40-53.
23. MacMicking, J., Xie, Q.W., and Nathan, C. (1997) Nitric oxide and macrophage function. Annu Rev Immunol 15: 323-350.
24. Miggin, S.M., and O'Neill, L.A. (2006) New insights into the regulation of TLR signaling. J Leukoc Biol 80: 220-226.
25. Miyagi, K., Kawakami, K., and Saito, A. (1997) Role of reactive nitrogen and oxygen intermediates in gamma interferon-stimulated murine macrophage bactericidal activity against Burkholderia pseudomallei. Infect Immun 65: 4108-4113.
26. Moore, R.A., DeShazer, D., Reckseidler, S., Weissman, A., and Woods, D.E. (1999) Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob Agents Chemother 43: 465-470.
27. Nierman, W.C., DeShazer, D., Kim, H.S., Tettelin, H., Nelson, K.E., Feldblyum, T., et al. (2004) Structural flexibility in the Burkholderia mallei genome. Proc Natl Acad Sci USA 101: 14246-14251.
28. Okemoto, K., Kawasaki, K., Hanada, K., Miura, M., and Nishijima, M. (2006) A potent adjuvant monophosphoryl lipid A triggers various immune responses, but not secretion of IL-1beta or activation of caspase-1. J Immunol 176: 1203-1208.
29. Pandey, S., and Agrawal, D.K. (2006) Immunobiology of Toll-like receptors: Emerging trends. Immunol Cell Biol 84: 333-341.
30. Redfearn, M.S., Palleroni, N.J., and Stanier, R.Y. (1966) A comparative study of Pseudomonas pseudomallei and Bacillus mallei. J Gen Microbiol 43: 293-313.
31. Ribot, W.J., and Ulrich, R.L. (2006) The animal pathogen-like type III secretion system is required for the intracellular survival of Burkholderia mallei within J774.2 macrophages. Infect Immun 74: 4349-4353.
32. Rottenberg, M.E., Gigliotti Rothfuchs, A., Gigliotti, D., Ceausu, M., Une, C., Levitsky, V., and Wigzell, H. (2000) Regulation and role of IFN-gamma in the innate resistance to infection with Chlamydia pneumoniae. J Immunol 164: 4812-4818.
33. Rotz, L.D., Khan, A.S., Lillibridge, S.R., Ostroff, S.M., and Hughes, J.M. (2002) Public health assessment of potential biological terrorism agents. Emerg Infect Dis 8: 225-230.
34. Saini, L.S., Galsworthy, S.B., John, M.A., and Valvano, M.A. (1999) Intracellular survival of Burkholderia cepacia complex isolates in the presence of macrophage cell activation. Microbiology 145 (Part 12): 3465-3475.
35. Schell, M.A., Ulrich, R.L., Ribot, W.J., Brueggemann, E.E., Hines, H.B., Chen, D., et al. (2007) Type VI secretion is a major virulence determinant in Burkholderia mallei. Mol Microbiol 64: 1466-1485.
36. Silipo, A., Molinaro, A., Cescutti, P., Bedini, E., Rizzo, R., Parrilli, M., and Lanzetta, R. (2005) Complete structural characterization of the lipid A fraction of a clinical strain of B.cepacia genomovar I lipopolysaccharide. Glycobiology 15: 561-570.
37. Smith, P.D., Smythies, L.E., and Wahl, S.M. (2001) Macrophage effector function. In Clinical Immunology: Principles and Practice. Rich, R.R., Fleisher, T.A., Shearer, W.T., Kotzin, B.L., and Schroeder, H.W., Jr. (eds). Mosby, pp. 19.1-19.
38. Srinivasan, A., Kraus, C.N., DeShazer, D., Becker, P.M., Dick, J.D., Spacek, L., et al. (2001) Glanders in a military research microbiologist. N Engl J Med 345: 256-258.
39. Stevens, J.M., Ulrich, R.L., Taylor, L.A., Wood, M.W., Deshazer, D., Stevens, M.P., and Galyov, E.E. (2005) Actin-binding proteins from Burkholderia mallei and Burkholderia thailandensis can functionally compensate for the actin-based motility defect of a Burkholderia pseudomallei bimA mutant. J Bacteriol 187: 7857-7862.
40. Stevens, M.P., Wood, M.W., Taylor, L.A., Monaghan, P., Hawes, P., Jones, P.W., et al. (2002) An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behaviour of the pathogen. Mol Microbiol 46: 649-659.
41. Takaoka, A., and Yanai, H. (2006) Interferon signalling network in innate defence. Cell Microbiol 8: 907-922.
42. Theofilopoulos, A.N., Baccala, R., Beutler, B., and Kono, D.H. (2005) Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23: 307-336.
43. Thomas, K.E., Galligan, C.L., Newman, R.D., Fish, E.N., and Vogel, S.N. (2006) Contribution of interferon-beta to the murine macrophage response to the toll-like receptor 4 agonist, lipopolysaccharide. J Biol Chem 281: 31119-31130.
44. Ulrich, R.L., and DeShazer, D. (2004) Type III secretion: A virulence factor delivery system essential for the pathogenicity of Burkholderia mallei. Infect Immun 72: 1150-1154.
45. Utaisincharoen, P., Tangthawornchaikul, N., Kespichayawattana, W., Anuntagool, N., Chaisuriya, P., and Sirisinha, S. (2000) Kinetic studies of the production of nitric oxide (NO) and tumour necrosis factor-alpha (TNF-alpha) in macrophages stimulated with Burkholderia pseudomallei endotoxin. Clin Exp Immunol 122: 324-329.
46. Utaisincharoen, P., Tangthawornchaikul, N., Kespichayawattana, W., Chaisuriya, P., and Sirisinha, S. (2001) Burkholderia pseudomallei interferes with inducible nitric oxide synthase (iNOS) production: A possible mechanism of evading macrophage killing. Microbiol Immunol 45: 307-313.
47. Utaisincharoen, P., Anuntagool, N., Limposuwan, K., Chaisuriya, P., and Sirisinha, S. (2003) Involvement of beta interferon in enhancing inducible nitric oxide synthase production and antimicrobial activity of Burkholderia pseudomallei -infected macrophages. Infect Immun 71: 3053-3057.
48. Utaisincharoen, P., Anuntagool, N., Arjcharoen, S., Limposuwan, K., Chaisuriya, P., and Sirisinha, S. (2004) Induction of iNOS expression and antimicrobial activity by interferon (IFN)-beta is distinct from IFN-gamma in Burkholderia pseudomallei -infected mouse macrophages. Clin Exp Immunol 136: 277-283.
49. Vazquez-Torres, A., and Fang, F.C. (2001) Oxygen-dependent anti- Salmonella activity of macrophages. Trends Microbiol 9: 29-33.
50. Waag, D.M., McCluskie, M.J., Zhang, N., and Krieg, A.M. (2006) A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei. Infect Immun 74: 1944-1948.
51. Weisz, A., Oguchi, S., Cicatiello, L., and Esumi, H. (1994) Dual mechanism for the control of inducible-type NO synthase gene expression in macrophages during activation by interferon-gamma and bacterial lipopolysaccharide. Transcriptional and post-transcriptional regulation. J Biol Chem 269: 8324-8333.
52. Wilkinson, L. (1981) Glanders: Medicine and veterinary medicine in common pursuit of a contagious disease. Med Hist 25: 363-384.
53. Yabuuchi, E., Kosako, Y., Oyaizu, H., Yano, I., Hotta, H., Hashimoto, Y., et al. (1992) Proposal of Burkholderia Gen. nov. & transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol Immunol 36: 1251-1275.
54. Zughaier, S.M., Zimmer, S.M., Datta, A., Carlson, R.W., and Stephens, D.S. (2005) Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins. Infect Immun 73: 2940-2950.